Anna Luisa Di Stefano, Co-Chair of the Scientific Panel on Neuro-Oncology for 2025–2028 at the European Academy of Neurology (EAN) and Neuro Oncologist at USL Tuscany Northwest, Spedali Riuniti di Livorno, shared a post on LinkedIn about a paper she co-authored with colleagues, published in The Oncologist:
“I’m happy to share our recent review article on IDH mutant glioma patients’ management.
Tumor sampling in advanced stages of the disease could matter and could drive medical therapy.
Let’s give a look at.”
Title: Advances in the management of patients with IDH-mutant glioma
Authors: Jessica Rossi, Alberto Picca, Orazio Santo Santonocito, Silvia Schembari, Lorenzo Testaverde, Marc Sanson, Giulia Berzero, and Anna Luisa Di Stefano.
You can read the Full Article in The Oncologist.
More posts featuring Anna Luisa Di Stefano.
